Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Eckert & Ziegler AG (EUZ) Ordinary NPV

Sell:€153.80 Buy:€154.40 Change: €0.1 (0.06%)
Market closed |  Prices as at close on 3 July 2020 | Switch to live prices |
Change: €0.1 (0.06%)
Market closed |  Prices as at close on 3 July 2020 | Switch to live prices |
Change: €0.1 (0.06%)
Market closed |  Prices as at close on 3 July 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Eckert & Ziegler Strahlen und Medizintechnik AG is a Germany-based provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

Contact details

+49 (30) 9410840

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
€815.12 million
Shares in issue:
5.15 million
Health Care Equipment

Key personnel

  • Wolfgang Maennig
    Chairman of the Supervisory Board
  • Andreas Eckert
    Chief Executive Officer, Chairman of the Management Board
  • Harald Hasselmann
    Member of the Management Board
  • Andre Hess
    Member of the Management Board
  • Gunnar Mann
    Member of the Group Executive Committee
  • Franklin Yeager
    Member of the Group Executive Committee

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.